Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDLIM4 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | EEFSEC | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | SEC31A | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | NRP2 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | TUBE1 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | RRAS | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | SYNPO | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | UBAP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | TAF11 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | SYS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |